BioNTech SE - ADR vs Capri Holdings Ltd — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Capri Holdings Ltd trades at $15.62 (market cap $1.75B). The key difference: BioNTech SE - ADR is far larger — about 13.3× Capri Holdings Ltd's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Capri Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| BNTX | CPRI | |
|---|---|---|
Market Cap | $23.31B | $1.75B |
Sector | Health | Consumer Staples |
52-Week High | $119.34 | $27.66 |
52-Week Low | $83.89 | $14.98 |
Enterprise Value | $6.60B | $3.03B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →